18F-FDG PET analysis of schwannoma: Increase of SUVmax in the delayed scan is correlated with elevated VEGF/VPF expression in the tumors

Skeletal Radiology

Volumn 38, Issue 3, 2009, Pages 261-266

  Hamada, Kenichiro ^a,b   Tomita, Yasuhiko ^a   Qiu, Ying ^b   Tomoeda, Miki ^a   Ueda, Takafumi ^c   Tamai, Noriyuki ^b   Hashimoto, Nobuyuki ^b   Yoshikawa, Hideki ^b   Aozasa, Katsuyuki ^b   Hatazawa, Jun ^b  

^a OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c OSAKA NATIONAL HOSPITAL   (Japan)

Author keywords

Glucose transporter; Hexokinase; Positron emission tomography; Schwannoma; Vascular endothelial growth factor vascular permeability

Indexed keywords

CD31 ANTIGEN; FLUORODEOXYGLUCOSE F 18; GLUCOSE; GLUCOSE TRANSPORTER 1; GLUCOSE TRANSPORTER 3; HEXOKINASE; HEXOKINASE 2; UNCLASSIFIED DRUG; VASCULOTROPIN;

ADULT; AGED; ARTICLE; BLOOD VESSEL PERMEABILITY; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC TEST; FEMALE; GLUCOSE TRANSPORT; HUMAN; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; MALE; MICROVASCULARIZATION; NEURILEMOMA; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR VOLUME; WHOLE BODY PET;

ADULT; AGED; ANALYSIS OF VARIANCE; FEMALE; FLUORODEOXYGLUCOSE F18; GLUCOSE TRANSPORTER TYPE 1; HEXOKINASE; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; NEURILEMMOMA; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; STATISTICS, NONPARAMETRIC; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 58849146075     PISSN: 03642348     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00256-008-0612-7     Document Type: Article

References (9)

1. LG Strauss PS Conti 1991 The applications of PET in clinical oncology J Nucl Med 32 623 648
2. R Kumar MR Nadig A Chauhan 2005 Positron emission tomography: clinical applications in oncology. Part 1 Expert Rev Anticancer Ther 5 1079 1094
3. 18FDG uptake in soft tissue masses Eur J Nucl Med 26 22 30
4. S Beaulieu B Rubin D Djang E Conrad E Turcotte JF Eary 2004 Positron emission tomography of schwannomas: emphasizing its potential in preoperative planning Am J Roentgenol 182 971 974
5. AR Ahmed H Watanabe J Aoki T Shinozaki K Takagishi 2001 Schwannoma of the extremities: the role of PET in preoperative planning Eur J Nucl Med 28 1541 1551
6. T Higashi T Saga Y Nakamoto 2002 Relationship between retention index in dual-phase (18)F-FDG PET, and hexokinase-II and glucose transporter-1 expression in pancreatic cancer J Nucl Med 43 173 180
7. M Mamede T Higashi M Kitaichi 2005 [18F]FDG uptake and PCNA, Glut-1, and Hexokinase-II expressions in cancers and inflammatory lesions of the lung Neoplasia 7 369 379
8. W Cai X Chen 2008 Multimodality molecular imaging of tumor angiogenesis J Nucl Med 49 113S 128S
9. JA Nagy L Benjamin H Zeng AM Dvorak HF Dvorak 2008 Vascular permeability, vascular hyperpermeability and angiogenesis Angiogenesis 11 109 119